Top

Current Obesity Reports

Published in:

08-11-2023 | Telemedicine | REVIEW

Pediatric Obesity Care via Telemedicine: Expanding the Path Forward—A Review

Authors: Valerie M. O’Hara, Danielle Louder, Starr V. Johnston, Kathrin Hastey, Nancy T. Browne

Published in: Current Obesity Reports | Issue 4/2023

Abstract

Purpose of Review

Review latest data regarding the intersection of pediatric obesity epidemic with telemedicine expansion to meet the need of equitable obesity care in children.

Recent Findings

Prevalence of pediatric obesity in the USA continues to worsen particularly in rural, underserved areas. Although there is an increasing number of obesity medicine specialists over the last decade, availability varies by geographic location. Pre-pandemic centers were limited, rarely located in rural areas, and required in-person visits for reimbursement. Telemedicine changes, responding to pandemic needs, provided increase in telemedicine utilization and acceptance with similar or improved obesity care outcomes.

Summary

Given pediatric obesity prevalence and need for chronic, effective obesity care, leveraging telemedicine to expand reach and decrease access barriers provides a critical and creative remedy. Data cites similar outcomes between telemedicine and in-person care. The time to reimagine a full spectrum of care delivery for pediatric obesity is now.

World Health Organization. World obesity day 2022. WHO. Accessed Jun 11, 2023. https://www.who.int/news/item/04-03-2022-world-obesity-day-2022-accelerating-action-to-stop-obesity.

Woodruff RC, Campbell AP, Taylor CA, Chai SJ, Kawasaki B, Meek J, Anderson EJ, Weigel A, Monroe ML, Reeg L, Bye E, Sosin DM, Muse A, Bennett NM, Billing LM, Sutton M, Talbot HK, McCaffrey K, Pham H, Patel K, Whitaker M, L McMorrow M, P Havers F. Risk factors for severe COVID-19 in children. Pediatrics. 2022;149(1):e2021053418. https://doi.org/10.1542/peds.2021-053418. Epub 2021 Dec 22. PMID: 34935038; PMCID: PMC9213563.

Ward ZJ, Long MW, Resch SC, Giles CM, Cradock AL, Gortmaker SL. Simulation of growth trajectories of childhood obesity into adulthood. N Engl J Med. 2017;377(22):2145–53. https://doi.org/10.1056/NEJMoa1703860. PMID: 29171811; PMCID: PMC9036858.CrossRefPubMedPubMedCentral

Gudzune KA, Johnson VR, Bramante CT, Stanford FC. Geographic availability of physicians certified by the American Board of Obesity Medicine relative to obesity prevalence. Obesity (Silver Spring). 2019;27(12):1958–1966. https://doi.org/10.1002/oby.22628. Epub 2019 Sep 13. PMID: 31515965; PMCID: PMC6868336.

Kaye AD, Okeagu CN, Pham AD, Silva RA, Hurley JJ, Arron BL, Sarfraz N, Lee HN, Ghali GE, Gamble JW, Liu H, Urman RD, Cornett EM. Economic impact of COVID-19 pandemic on healthcare facilities and systems: international perspectives. Best Pract Res Clin Anaesthesiol. 2021;35(3):293–306. https://doi.org/10.1016/j.bpa.2020.11.009. Epub 2020 Nov 17. PMID: 34511220; PMCID: PMC7670225.

• Cuda S, Censani M, Kharofa R, O'Hara V, Conroy R, Williams D, Paisley J, Browne A, Karjoo S, Browne NT. Medication-induced weight gain and advanced therapies for the child with overweight and obesity: an Obesity Medicine Association (OMA) Clinical Practice Statement 2022, Obesity Pillars. 2022;4:100048, ISSN 2667–3681. https://doi.org/10.1016/j.obpill.2022.100048. Provides comprehensive review of advanced treatment for pediatric obesity.

O’Hara V, Cuda S, Kharofa R, Censani M, Conroy R, Browne NT. Clinical review: guide to pharmacological management in pediatric obesity medicine. Obesity Pillars. 2023;6:100066, ISSN 2667–3681. https://doi.org/10.1016/j.obpill.2023.100066.

Flattum C, Friend S, Horning M, Lindberg R, Beaudette J, Fulkerson JA. Family-focused obesity prevention program implementation in urban versus rural communities: a case study. BMC Public Health. 2021;21(1):1915. https://doi.org/10.1186/s12889-021-11967-3. PMID: 34674674; PMCID: PMC8532281.CrossRefPubMedPubMedCentral

SanGiovanni C, McElligott J, Morella K, Basco W Jr. Underdiagnosis and lower rates of office visits for overweight/obese pediatric patients in rural compared with urban areas. South Med J. 2017;110(7):480–5. https://doi.org/10.14423/SMJ.0000000000000672. PMID: 28679018.CrossRefPubMed

10.

Strochlic R, Au LE, Ritchie L. Is urban-rural location associated with weight status in school children? An examination of 42 small and rural Californian counties. Rural Remote Health. 2017;17(2):3966. https://doi.org/10.22605/RRH3966. Epub 2017 Apr 18. PMID: 28415846.

11.

Ogden CL, Fryar CD, Hales CM, Carroll MD, Aoki Y, Freedman DS. Differences in obesity prevalence by demographics and urbanization in US children and adolescents, 2013–2016. JAMA. 2018;319(23):2410–8. https://doi.org/10.1001/jama.2018.5158. PMID: 29922826; PMCID: PMC6393914 .CrossRefPubMedPubMedCentral

12.

Srivastava G, Browne N, Kyle TK, O’Hara V, Browne A, Nelson T, Puhl R. Caring for US children: barriers to effective treatment in children with the disease of obesity. Obesity (Silver Spring). 2021;29(1):46–55. https://doi.org/10.1002/oby.22987. PMID: 34494365.CrossRefPubMed

13.

Halford JCG, Bereket A, Bin-Abbas B, Chen W, Fernández-Aranda F, Garibay Nieto N, López Siguero JP, Maffeis C, Mooney V, Osorto CK, Reynoso R, Rhie YJ, Toro-Ramos M, Baur LA. Misalignment among adolescents living with obesity, caregivers, and healthcare professionals: ACTION Teens global survey study. Pediatr Obes. 2022;17(11):e12957. https://doi.org/10.1111/ijpo.12957. Epub 2022 Jul 15. PMID: 35838551.

14.

• Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, Avila Edwards KC, Eneli I, Hamre R, Joseph MM, Lunsford D, Mendonca E, Michalsky MP, Mirza N, Ochoa ER, Sharifi M, Staiano AE, Weedn AE, Flinn SK, Lindros J, Okechukwu K. Clinical Practice Guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151(2):e2022060640. https://doi.org/10.1542/peds.2022-060640. Important first AAP CPG since 2007 highlighting the need to treat obesity as a chronic disease using all available therapies.CrossRefPubMed

15.

Di Cesare M, Sorić M, Bovet P, Miranda JJ, Bhutta Z, Stevens GA, Laxmaiah A, Kengne AP, Bentham J. The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action. BMC Med. 2019;17(1):212. https://doi.org/10.1186/s12916-019-1449-8. PMID: 31760948; PMCID: PMC6876113.CrossRefPubMedPubMedCentral

16.

Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, Mastrandrea LD, Prabhu N, Arslanian S; NN8022–4180 Trial Investigators. A randomized, controlled trial of Liraglutide for adolescents with obesity. N Engl J Med. 2020;382(22):2117–2128. https://doi.org/10.1056/NEJMoa1916038. Epub 2020 Mar 31. PMID: 32233338.

17.

Kelly AS, Bensignor MO, Hsia DS, Shoemaker AH, Shih W, Peterson C, Varghese ST. Phentermine/topiramate for the treatment of adolescent obesity. NEJM Evid. 2022. https://doi.org/10.1056/evidoa2200014. Epub 2022 Apr 30. PMID: 36968652; PMCID: PMC10035585.

18.

Weghuber D, Barrett T, Barrientos-Pérez M, Gies I, Hesse D, Jeppesen OK, Kelly AS, Mastrandrea LD, Sørrig R, Arslanian S; STEP TEENS Investigators. Once-weekly semaglutide in adolescents with obesity. N Engl J Med. 2022;387(24):2245–2257. https://doi.org/10.1056/NEJMoa2208601. Epub 2022 Nov 2. PMID: 36322838; PMCID: PMC9997064.

19.

Clément K, van den Akker E, Argente J, Bahm A, Chung WK, Connors H, De Waele K, Farooqi IS, Gonneau-Lejeune J, Gordon G, Kohlsdorf K, Poitou C, Puder L, Swain J, Stewart M, Yuan G, Wabitsch M, Kühnen P; Setmelanotide POMC and LEPR Phase 3 Trial Investigators. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diab Endocrinol. 2020;8(12):960–970. https://doi.org/10.1016/S2213-8587(20)30364-8. Epub 2020 Oct 30. PMID: 33137293.

20.

Cuda S, Censani M. Progress in pediatric obesity: new and advanced therapies. Curr Opin Pediatr. 2022;34(4):407–13. https://doi.org/10.1097/MOP.0000000000001150. Epub 2022 Jul 5 PMID: 35797460.CrossRefPubMed

21.

Lazareva J, Brady SM, Yanovski JA. An evaluation of setmelanotide injection for chronic weight management in adult and pediatric patients with obesity due to Bardet-Biedl syndrome. Expert Opin Pharmacother. 2023;24(6):667–674. https://doi.org/10.1080/14656566.2023.2199152. Epub 2023 Apr 6. PMID: 37013719; PMCID: PMC10121918.

22.

Gross AC, Kaizer AM, Kelly AS, Rudser KD, Ryder JR, Borzutzky CR, Santos M, Tucker JM, Yee JK, Fox CK; POWER Work Group. Long and short of it: early response predicts longer-term outcomes in pediatric weight management. Obesity (Silver Spring). 2019;27(2):272–279. https://doi.org/10.1002/oby.22367. PMID: 30677263; PMCID: PMC6352906.

23.

Herdes RE, Tsao DD, Pratt JSA. Why earlier may be better: a look at the use of metabolic and bariatric surgery in the treatment of severe childhood obesity. Surg Obes Relat Dis. 2021;17(12):2107–10. https://doi.org/10.1016/j.soard.2021.09.003. (Epub 2021 Sep 8 PMID: 34565685).CrossRefPubMed

24.

Borzutzky C, King E, Fox CK, Stratbucker W, Tucker J, Yee JK, Kumar S, Cuda S, Sweeney B, Kirk S, On Behalf Of The Power Work Group. Trends in prescribing anti-obesity pharmacotherapy for paediatric weight management: data from the POWER Work Group. Pediatr Obes. 2021;16(1):e12701. https://doi.org/10.1111/ijpo.12701. Epub 2020 Sep 2. PMID: 32877010.

25.

• Woo Baidal JA, Chang J, Hulse E, Turetsky R, Parkinson K, Rausch JC. Zooming toward a telehealth solution for vulnerable children with obesity during coronavirus disease 2019. Obesity (Silver Spring). 2020;28(7):1184–1186. https://doi.org/10.1002/oby.22860. Epub 2020 Jun 10. PMID: 32352650; PMCID: PMC7267304. Provides a review of utility of telemedicine for children with obesity which was highlighted during COVID.

26.

Project ECHO. University of New Mexico. Accessed June 11, 2023. Available at https://hsc.unm.edu/echo/.

27.

Lewiecki EM, Rochelle R. Project ECHO: telehealth to expand capacity to deliver best practice medical care. Rheum Dis Clin North Am. 2019;45(2):303–14. https://doi.org/10.1016/j.rdc.2019.01.003.CrossRefPubMed

28.

Novick MB, Wilson CT, Walker-Harding LR. Potential solutions for pediatric weight loss programs in the treatment of obesity in rural communities. Transl Behav Med. 2019;9(3):460–7. https://doi.org/10.1093/tbm/ibz030.CrossRefPubMed

29.

Updated telehealth and telemedicine timeline. Accessed June 11, 2023. https://www.umtrc.org/clientuploads/UMTRC%20Resource%20PDF/Updated_Telehealth_and_Telemedicine_Timeline.pdf.

30.

•• Centers for Medicare and Medicaid Services. COVID-19 emergency declaration blanket waivers for health care providers. Updated October 13, 2023. Accessed June 11, 2023. Available at COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers (cms.gov). Important reference for all providers using telehealth now and going forward after PHE.

31.

Assistant Secretary for Planning and Evaluation. Medicare beneficiaries’ use of telehealth in 2020: trends by beneficiary characteristics and location. ASPE Office of Health Policy Research. Published December 2021. Accessed June 11, 2023. https://aspe.hhs.gov/sites/default/files/documents/a1d5d810fe3433e18b192be42dbf2351/medicare-telehealth-report.pdf.

32.

Center for Connected Health Policy. Medicare telehealth/connected health waivers post-PHE. Published March 2, 2023. Accessed June 11, 2023 at https://www.cchpca.org/2023/03/MEDICARE-TELEHEALTH-POLICIES-POST-PHE-AT-A-GLANCE-FINAL-MAR-2023.pdf.

33.

Drug Enforcement Association & Health and Human Services Department. Temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications. Published May 10, 2023. Accessed June 11, 2023 at https://www.federalregister.gov/documents/2023/05/10/2023-09936/temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled.

34.

National Center for Interstate Compacts. Interstate licensure compacts. Accessed June 11, 2023. https://compacts.csg.org/covid-policy-responses/interstate-licensure-compacts/.

35.

Fang ML, Walker M, Wong KLY, Sixsmith J, Remund L, Sixsmith A. Future of digital health and community care: exploring intended positive impacts and unintended negative consequences of COVID-19. Healthc Manage Forum. 2022;35(5):279–285. https://doi.org/10.1177/08404704221107362. Epub 2022 Jul 1. PMID: 35775162; PMCID: PMC9253718.

36.

U.S. Department of Commerce National Telecommunications and Information Administration. Digital Equity Plan Guidance. https://broadbandusa.ntia.gov/sites/default/files/2022-09/Digital_Equity_Plan_Guidance.pdf. Accessed 11 June 2023.

37.

Federal Communications Commission. Chairman Pai Archive: Bridging The Digital Divide For All Americans. Accessed June 11, 2023 at https://www.fcc.gov/ajit-pai-initiatives-archive.

38.

Friedman AB, Gervasi S, Song H, Bond AM, Chen AT, Bergman A, David G, Bailey JM, Brooks R, Smith-McLallen A. Telemedicine catches on: changes in the utilization of telemedicine services during the COVID-19 pandemic. Am J Manag Care. 2022;28(1):e1–6. https://doi.org/10.37765/ajmc.2022.88771. PMID: 35049260.CrossRefPubMed

39.

North S. Expanding telehealth in adolescent care: moving beyond the COVID-19 pandemic. Pediatrics. 2023;151(Suppl 1):e2022057267J. https://doi.org/10.1542/peds.2022-057267J. PMID: 37010401.CrossRefPubMed

40.

Notario PM, Gentile E, Amidon M, Angst D, Lefaiver C, Webster K. Home-based telemedicine for children with medical complexity. Telemed J E Health. 2019 Nov;25(11):1123–1132. https://doi.org/10.1089/tmj.2018.0186. Epub 2019 Jan 30. PMID: 30628860; PMCID: PMC6842894

41.

Moorman EL, Koskela-Staples NC, Mathai BB, Fedele DA, Janicke DM. Pediatric obesity treatment via telehealth: current evidence and future directions. Curr Obes Rep. 2021;10(3):371–84. https://doi.org/10.1007/s13679-021-00446-w. Epub 2021 Jul 24 PMID: 34302603.CrossRefPubMed

42.

Qiu LT, Sun GX, Li L, Zhang JD, Wang D, Fan BY. Effectiveness of multiple eHealth-delivered lifestyle strategies for preventing or intervening overweight/obesity among children and adolescents: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;5(13):999702. https://doi.org/10.3389/fendo.2022.999702. PMID: 36157474; PMCID: PMC9491112 .CrossRef

43.

Srivastava G, Fox CK, Kelly AS, Jastreboff AM, Browne AF, Browne NT, Pratt JSA, Bolling C, Michalsky MP, Cook S, Lenders CM, Apovian CM. Clinical considerations regarding the use of obesity pharmacotherapy in adolescents with obesity. Obesity (Silver Spring). 2019;27(2):190–204. https://doi.org/10.1002/oby.22385. PMID: 30677262; PMCID: PMC6449849 .CrossRefPubMed

44.

• O'Hara VM, Johnston SV, Browne NT. The paediatric weight management office visit via telemedicine: pre- to post-COVID-19 pandemic. Pediatr Obes. 2020;15(8):e12694. https://doi.org/10.1111/ijpo.12694. Epub 2020 Jul 6. PMID: 32627434; PMCID: PMC7361154. Provides pre-pandemic to post-pandemic pediatric clinical care in a multidisciplinary setting experience along with important telehealth policies.

45.

•• DeSilva S, Vaidya SS. The application of telemedicine to pediatric obesity: lessons from the past decade. Telemed J e-Health. 2021;27(2):159–66. https://doi.org/10.1089/tmj.2019.0314. Provides important 10-year review specifically for pediatric obesity using telemedicine.CrossRefPubMed

46.

Pecoraro P, Gallè F, Muscariello E, Di Mauro V, Daniele O, Forte S, Ricchiuti R, Liguori G, Valerio G. A telehealth intervention for ensuring continuity of care of pediatric obesity during the CoVid-19 lockdown in Italy. Nutr Metab Cardiovasc Dis. 2021;31(12):3502–3507. https://doi.org/10.1016/j.numecd.2021.09.026. Epub 2021 Oct 7. PMID: 34728130; PMCID: PMC8496959.

47.

Calcaterra V, Verduci E, Vandoni M, Rossi V, Di Profio E, CarnevalePellino V, Tranfaglia V, Pascuzzi MC, Borsani B, Bosetti A, Zuccotti G. Telehealth: a useful tool for the management of nutrition and exercise programs in pediatric obesity in the COVID-19 era. Nutrients. 2021;13(11):3689. https://doi.org/10.3390/nu13113689. PMID: 34835945; PMCID: PMC8618189.CrossRefPubMedPubMedCentral

48.

• Kouvari M, Karipidou M, Tsiampalis T, et al. Digital health interventions for weight management in children and adolescents: systematic review and meta-analysis. J Med Internet Res. 2022;24(2):e30675. Published 2022 Feb 14. https://doi.org/10.2196/30675. Review of telehealth tools in hybrid model, need for more research for fully telehealth delivery.

49.

Whitley A, Yahia N. Efficacy of clinic-based telehealth vs. face-to-face interventions for obesity treatment in children and adolescents in the United States and Canada: a systematic review. Child Obes. 2021;17(5):299–310. https://doi.org/10.1089/chi.2020.0347. Epub 2021 Apr 29. PMID: 33926238.

50.

• Umano GR, Di Sessa A, Guarino S, Gaudino G, Marzuillo P, Miraglia Del Giudice E. Telemedicine in the COVID-19 era: taking care of children with obesity and diabetes mellitus. World J Diabetes. 2021;12(5):651–7. https://doi.org/10.4239/wjd.v12.i5.651. PMID: 33995852; PMCID: PMC8107973. Discusses impact of telemedicine on obesity and related complication of diabetes during covid.CrossRefPubMedPubMedCentral

51.

Rajkumar E, Gopi A, Joshi A, et al. Applications, benefits, and challenges of telehealth in India during COVID-19 pandemic and beyond: a systematic review. BMC Health Serv Res. 2023;23(1):7. Published 2023 Jan 4. https://doi.org/10.1186/s12913-022-08970-8

52.

Aras M, Tchang BG, Crawford A, Bledsoe M, Fujioka K, Aronne LJ. Impact of telemedicine during the COVID-19 pandemic on patient attendance. Obesity (Silver Spring). 2021;29(7):1093–1094. https://doi.org/10.1002/oby.23180. Epub 2021 May 7. PMID: 33963678; PMCID: PMC8242458.

53.

• Tchang BG, Morrison C, Kim JT, Ahmed F, Chan KM, Alonso LC, Aronne LJ, Shukla AP. Weight loss outcomes with telemedicine during COVID-19. Front Endocrinol (Lausanne). 2022;10(13):793290. https://doi.org/10.3389/fendo.2022.793290. PMID: 35360066; PMCID: PMC8960113. Provides data comparing various delivery models for obesity medicine care with clinical outcomes across telemedicine, hybrid, and face-to-face comparison. Highlights the need for pediatric data regarding similar study.CrossRef

54.

•• Crawford A, Serhal E. Digital health equity and COVID-19: the innovation curve cannot reinforce the social gradient of health. J Med Internet Res. 2020;22(6):e19361. https://doi.org/10.2196/19361. PMID: 32452816; PMCID: PMC7268667. Provides important perspectives on equity as well as insights for potential solutions.CrossRefPubMedPubMedCentral

55.

Cueto V, Sanders LM. Telehealth opportunities and challenges for managing pediatric obesity. Pediatr Clin North Am. 2020;67(4):647–54. https://doi.org/10.1016/j.pcl.2020.04.007. PMID: 32650862.CrossRefPubMed

56.

• Christison AL, Ariza AJ, Fernandez C, Kumar S, Novick MB, Santos M, Stratbucker WB, Sweeney BR, Vidmar A, Kirk S. Challenges and solutions to sustaining paediatric weight management programs in the United States. Clin Obes. 2023;11:e12577. https://doi.org/10.1111/cob.12577. Epub ahead of print. PMID: 36631245. Addresses multiple considerations regarding sustaining pediatric obesity care assess, telemedicine a key factor learned because of the pandemic experience.

57.

Kaplan LM, Golden A, Jinnett K, Kolotkin RL, Kyle TK, Look M, Nadglowski J, O’Neil PM, Parry T, Tomaszewski KJ, Stevenin B, Lilleøre SK, Dhurandhar NV. Perceptions of barriers to effective obesity care: results from the national ACTION Study. Obesity (Silver Spring). 2018;26(1):61–9. https://doi.org/10.1002/oby.22054. Epub 2017 Oct 31 PMID: 29086529.CrossRefPubMed

58.

Puhl RM, Lessard LM. Weight stigma in youth: prevalence, consequences, and considerations for clinical practice. Curr Obes Rep. 2020;9(4):402–11. https://doi.org/10.1007/s13679-020-00408-8. Epub 2020 Oct 20 PMID: 33079337.CrossRefPubMed

59.

Pearl R, Wayling B. The telehealth era is just beginning. Harv Bus Rev. 2022. https://hbr.org/2022/05/the-telehealth-era-is-just-beginning.

Title: Pediatric Obesity Care via Telemedicine: Expanding the Path Forward—A Review
Authors: Valerie M. O’Hara
Danielle Louder
Starr V. Johnston
Kathrin Hastey
Nancy T. Browne
Publication date: 08-11-2023
Publisher: Springer US
Keywords: Telemedicine
Pediatric Obesity
Obesity
Obesity
Care
Published in: Current Obesity Reports / Issue 4/2023
Electronic ISSN: 2162-4968
DOI: https://doi.org/10.1007/s13679-023-00537-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2023

Genetics and Epigenetics in Obesity: What Do We Know so Far?

Safe and effective use of drugs in people with obesity

Upstream Determinants of Overweight and Obesity in Europe

Ketogenic Diet: A Nutritional Therapeutic Tool for Lipedema?

Revisiting Resting Metabolic Rate: What is the Relation to Weight Fluctuations?

Correction: The Effectiveness of eHealth Interventions for Weight Loss and Weight Loss Maintenance in Adults with Overweight or Obesity: A Systematic Review of Systematic Reviews

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage